Insider Trading History of Vhcp Management Ii, Llc

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Vhcp Management Ii, Llc since 2014. The trader's CIK number is 1602263. At the time of the last reporting, Vhcp Management Ii, Llc was the 10% Owner of Bellerophon Therapeutics, Inc.. (stock ticker symbol BLPH). Also see all insider trading activities at Bellerophon Therapeutics, Inc..

Note that in the past VHCP Management II, LLC also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Adverum Biotechnologies, Inc. (AAVL) by Vhcp Management Ii, Llc

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2014 AAVL 400,000 $6,800,000 0 $0 0 $0

Yearly summary of insider trading at Bellerophon Therapeutics, Inc. (BLPH) by Vhcp Management Ii, Llc

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 BLPH 0 $0 1,093,847 $525,430 0 $0


Insider trading activities at 2 companies by Vhcp Management Ii, Llc:

1. Adverum Biotechnologies, Inc. (AAVL)

2. Bellerophon Therapeutics, Inc. (BLPH)

Table 1. Insider trading of Adverum Biotechnologies, Inc. (AAVL) by Vhcp Management Ii, Llc

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2014-08-05 AAVL Buy 400,000 17.00 6,800,000

Table 2. Insider trading of Bellerophon Therapeutics, Inc. (BLPH) by Vhcp Management Ii, Llc

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-10-25 BLPH Sale 56,242 .45 25,533
2019-10-24 BLPH Sale 704,595 .50 353,706
2019-10-28 BLPH Sale 333,010 .44 146,191

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Vhcp Management Ii, Llc (10% Owner of Bellerophon Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.